Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Paul Plotz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Autophagy

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
49
Raben, Nina
33
Miller, Frederick
20
Nagaraju, Kanneboyina
11
KLIPPEL, JOHN
11
Dalakas, Marinos
10
Targoff, Ira
9
Adams, EM
8
Rider, Lisa
7
O'Hanlon, Terrance
7
Hicks, Jeanne
6
Casciola-Rosen, Livia
6
Oddis, Chester
6
Rosen, Antony
5
Wilder, Ronald
5
Ralston, Evelyn

Sign-in to see all Coauthors

Publications

TOP 3
Takikita Shoichi; Myerowitz Rachel; Schreiner Cynthia; Baum Rebecca; Raben Nina; Plotz Paul H
The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' men...
Takikita Shoichi; Myerowitz Rachel; Zaal Kristien; Raben Nina; Plotz Paul H
Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.
Harris-Love M O; Shrader J A; Koziol D; Pahlajani N; Jain M; Smith M; Cintas H L; McGarvey C L; James-Newton L; Pokrovnichka A; Moini B; Cabalar I; Lovell D J; Wesley R; Plotz P H; Miller F W; Hicks J E; Rider L G
Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paul Plotz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Takikita Shoichi; Myerowitz Rachel; Schreiner Cynthia; Baum Rebecca; Raben Nina; Plotz Paul H
The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' men...
Autophagy 2009;5(5):729-31.
2009: Takikita Shoichi; Myerowitz Rachel; Zaal Kristien; Raben Nina; Plotz Paul H
Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.
Molecular genetics and metabolism 2009;96(4):208-17.
2009: Harris-Love M O; Shrader J A; Koziol D; Pahlajani N; Jain M; Smith M; Cintas H L; McGarvey C L; James-Newton L; Pokrovnichka A; Moini B; Cabalar I; Lovell D J; Wesley R; Plotz P H; Miller F W; Hicks J E; Rider L G
Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis.
Rheumatology (Oxford, England) 2009;48(2):134-9.
2009: Raben Nina; Baum Rebecca; Schreiner Cynthia; Takikita Shoichi; Mizushima Noboru; Ralston Evelyn; Plotz Paul
When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.
Autophagy 2009;5(1):111-3.
2009: Raben Nina; Shea Lauren; Hill Victoria; Plotz Paul
Monitoring autophagy in lysosomal storage disorders.
Methods in enzymology 2009;453():417-49.
2008: Raben Nina; Hill Victoria; Shea Lauren; Takikita Shoichi; Baum Rebecca; Mizushima Noboru; Ralston Evelyn; Plotz Paul
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease.
Human molecular genetics 2008;17(24):3897-908.
2008: Ralston E; Swaim B; Czapiga M; Hwu W-L; Chien Y-H; Pittis M G; Bembi B; Schwartz O; Plotz P; Raben N
Detection and imaging of non-contractile inclusions and sarcomeric anomalies in skeletal muscle by second harmonic generation combined with two-photon excited fluorescence.
Journal of structural biology 2008;162(3):500-8.
2008: Nagaraju Kanneboyina; Rawat Rashmi; Veszelovszky Edina; Thapliyal Rachana; Kesari Akanchha; Sparks Susan; Raben Nina; Plotz Paul; Hoffman Eric P
Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
The American journal of pathology 2008;172(3):774-85.
2007: Raben Nina; Takikita Shoichi; Pittis Maria G; Bembi Bruno; Marie Suely K N; Roberts Ashley; Page Laura; Kishnani Priya S; Schoser Benedikt G H; Chien Yin-Hsiu; Ralston Evelyn; Nagaraju Kanneboyina; Plotz Paul H
Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand...
Autophagy 2007;3(6):546-52.
2007: Raben N; Roberts A; Plotz P H
Role of autophagy in the pathogenesis of Pompe disease.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases 2007;26(1):45-8.
2007: Fukuda Tokiko; Roberts Ashley; Plotz Paul H; Raben Nina
Acid alpha-glucosidase deficiency (Pompe disease).
Current neurology and neuroscience reports 2007;7(1):71-7.
2006: Fukuda Tokiko; Ahearn Meghan; Roberts Ashley; Mattaliano Robert J; Zaal Kristien; Ralston Evelyn; Plotz Paul H; Raben Nina
Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(6):831-9.
2006: Fukuda Tokiko; Roberts Ashley; Ahearn Meghan; Zaal Kristien; Ralston Evelyn; Plotz Paul H; Raben Nina
Autophagy and lysosomes in Pompe disease.
Autophagy 2006;2(4):318-20.
2006: Fukuda Tokiko; Ewan Lindsay; Bauer Martina; Mattaliano Robert J; Zaal Kristien; Ralston Evelyn; Plotz Paul H; Raben Nina
Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease.
Annals of neurology 2006;59(4):700-8.
2006: O'Hanlon Terrance P; Carrick Danielle Mercatante; Targoff Ira N; Arnett Frank C; Reveille John D; Carrington Mary; Gao Xiaojiang; Oddis Chester V; Morel Penelope A; Malley James D; Malley Karen; Shamim Ejaz A; Rider Lisa G; Chanock Stephen J; Foster Charles B; Bunch Thomas; Blackshear Perry J; Plotz Paul H; Love Lori A; Miller Frederick W
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
Medicine 2006;85(2):111-27.
2006: Nagaraju Kanneboyina; Rider Lisa G; Fan Chenguang; Chen Yi-Wen; Mitsak Megan; Rawat Rashmi; Patterson Kathleen; Grundtman Cecilia; Miller Frederick W; Plotz Paul H; Hoffman Eric; Lundberg Ingrid E
Endothelial cell activation and neovascularization are prominent in dermatomyositis.
Journal of autoimmune diseases 2006;3():2.
2005: O'Hanlon Terrance P; Carrick Danielle Mercatante; Arnett Frank C; Reveille John D; Carrington Mary; Gao Xiaojiang; Oddis Chester V; Morel Penelope A; Malley James D; Malley Karen; Dreyfuss Jonathan; Shamim Ejaz A; Rider Lisa G; Chanock Stephen J; Foster Charles B; Bunch Thomas; Plotz Paul H; Love Lori A; Miller Frederick W
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.
Medicine 2005;84(6):338-49.
2005: Sarkar Kakali; Weinberg Clarice R; Oddis Chester V; Medsger Thomas A; Plotz Paul H; Reveille John D; Arnett Frank C; Targoff Ira N; Genth Ekkehard; Love Lori A; Miller Frederick W
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
Arthritis and rheumatism 2005;52(8):2433-8.
2005: Nagaraju Kanneboyina; Casciola-Rosen Livia; Lundberg Ingrid; Rawat Rashmi; Cutting Shawna; Thapliyal Rachana; Chang Jason; Dwivedi Sunita; Mitsak Megan; Chen Yi-Wen; Plotz Paul; Rosen Antony; Hoffman Eric; Raben Nina
Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.
Arthritis and rheumatism 2005;52(6):1824-35.
2005: Oppenheim Joost J; Dong Hui Fang; Plotz Paul; Caspi Rachel R; Dykstra Michelle; Pierce Susan; Martin Roland; Carlos Casey; Finn Olivera; Koul Omanand; Howard O M Zack
Autoantigens act as tissue-specific chemoattractants.
Journal of leukocyte biology 2005;77(6):854-61.
2005: Howard O M Zack; Dong Hui Fang; Su Shao Bo; Caspi Rachel R; Chen Xin; Plotz Paul; Oppenheim Joost J
Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate.
Blood 2005;105(11):4207-14.
2005: Casciola-Rosen Livia; Nagaraju Kanneboyina; Plotz Paul; Wang Kondi; Levine Stuart; Gabrielson Edward; Corse Andrea; Rosen Antony
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.
The Journal of experimental medicine 2005;201(4):591-601.
2005: Raben Nina; Fukuda Tokiko; Gilbert Abigail L; de Jong Deborah; Thurberg Beth L; Mattaliano Robert J; Meikle Peter; Hopwood John J; Nagashima Kunio; Nagaraju Kanneboyina; Plotz Paul H
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(1):48-56.
2004: Christopher-Stine Lisa; Plotz Paul H
Myositis: an update on pathogenesis.
Current opinion in rheumatology 2004;16(6):700-6.
2004: Miller F W; Rider L G; Plotz P H; Rutkove S B; Pestronk A; Wortmann R L; Lundberg I E; Argov Z; Isenberg D A; Lacomis D; Oddis C V
Polymyositis: an overdiagnosed entity.
Neurology 2004;63(2):402; author reply 403.
2004: Plotz P
The place of autoimmunity in myositis.
Autoimmunity reviews 2004;3 Suppl 1():S36.
2004: Christopher-Stine Lisa; Plotz Paul H
Adult inflammatory myopathies.
Best practice & research. Clinical rheumatology 2004;18(3):331-44.
2004: Isenberg D A; Allen E; Farewell V; Ehrenstein M R; Hanna M G; Lundberg I E; Oddis C; Pilkington C; Plotz P; Scott D; Vencovsky J; Cooper R; Rider L; Miller F;
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
Rheumatology (Oxford, England) 2004;43(1):49-54.
2003: Miller Frederick W; Rider Lisa G; Plotz Paul H; Isenberg David A; Oddis Chester V
Diagnostic criteria for polymyositis and dermatomyositis.
Lancet 2003;362(9397):1762-3; author reply 1763.
2003: Raben N; Danon M; Gilbert A L; Dwivedi S; Collins B; Thurberg B L; Mattaliano R J; Nagaraju K; Plotz P H
Enzyme replacement therapy in the mouse model of Pompe disease.
Molecular genetics and metabolism 2003;80(1-2):159-69.
2003: Raben Nina; Nagaraju Kanneboyina; Lee Alicia; Lu Nina; Rivera Yesenia; Jatkar Tejas; Hopwood John J; Plotz Paul H
Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice.
Transgenic research 2003;12(2):171-8.
2003: Plotz Paul H
The autoantibody repertoire: searching for order.
Nature reviews. Immunology 2003;3(1):73-8.
2002: Nagaraju Kanneboyina; Plotz Paul H
Animal models of myositis.
Rheumatic diseases clinics of North America 2002;28(4):917-33.
2002: Raben Nina; Jatkar Tejas; Lee Alicia; Lu Nina; Dwivedi Sunita; Nagaraju Kanneboyina; Plotz Paul H
Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(5):601-8.
2002: Martiniuk Frank; Chen Agnes; Mack Adra; Donnabella Vincent; Slonim Alfred; Bulone Linda; Arvanitopoulos Eleni; Raben Nina; Plotz Paul; Rom William N
Helios gene gun particle delivery for therapy of acid maltase deficiency.
DNA and cell biology 2002;21(10):717-25.
2002: Howard O M Zack; Dong Hui Fang; Yang De; Raben Nina; Nagaraju Kanneboyina; Rosen Antony; Casciola-Rosen Livia; Härtlein Michael; Kron Michael; Yang David; Yiadom Kwabena; Dwivedi Sunita; Plotz Paul H; Oppenheim Joost J
Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.
The Journal of experimental medicine 2002;196(6):781-91.
2002: Yan Bo; Raben Nina; Plotz Paul
The human acid alpha-glucosidase gene is a novel target of the Notch-1/Hes-1 signaling pathway.
The Journal of biological chemistry 2002;277(33):29760-4.
2002: Fraites Thomas J; Schleissing Mary R; Shanely R Andrew; Walter Glenn A; Cloutier Denise A; Zolotukhin Irene; Pauly Daniel F; Raben Nina; Plotz Paul H; Powers Scott K; Kessler Paul D; Byrne Barry J
Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(5 Pt 1):571-8.
2002: Raben Nina; Plotz Paul; Byrne Barry J
Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).
Current molecular medicine 2002;2(2):145-66.
2002: Yan Bo; Raben Nina; Plotz Paul H
Hes-1, a known transcriptional repressor, acts as a transcriptional activator for the human acid alpha-glucosidase gene in human fibroblast cells.
Biochemical and biophysical research communications 2002;291(3):582-7.
2002: Oppenheim Joost J; Yang De; Biragyn Arya; Howard O M Zack; Plotz Paul
Chemokine receptors on dendritic cells promote autoimmune reactions.
Arthritis research 2002;4 Suppl 3():S183-8.
2001: Raben N; Lu N; Nagaraju K; Rivera Y; Lee A; Yan B; Byrne B; Meikle P J; Umapathysivam K; Hopwood J J; Plotz P H
Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy.
Human molecular genetics 2001;10(19):2039-47.
2001: Yan B; Raben N; Lu N; Plotz P H
Identification and characterization of a tissue-specific silencer element in the first intron of the human acid maltase gene.
Human genetics 2001;109(2):186-90.
2001: Raben N; Danon M; Lu N; Lee E; Shliselfeld L; Skurat A V; Roach P J; Lawrence J C; Musumeci O; Shanske S; DiMauro S; Plotz P
Surprises of genetic engineering: a possible model of polyglucosan body disease.
Neurology 2001;56(12):1739-45.
2001: Pauly D F; Fraites T J; Toma C; Bayes H S; Huie M L; Hirschhorn R; Plotz P H; Raben N; Kessler P D; Byrne B J
Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease.
Human gene therapy 2001;12(5):527-38.
2001: Casciola-Rosen L A; Pluta A F; Plotz P H; Cox A E; Morris S; Wigley F M; Petri M; Gelber A C; Rosen A
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen.
Arthritis and rheumatism 2001;44(2):389-96.
2001: Plotz P H; Miller F; Hoffman E; Casciola-Rosen L; Rosen A
Workshop on inflammatory myopathy Bethesda, 5-6 April 2000.
Neuromuscular disorders : NMD 2001;11(1):93-5.
2001: Yan B; Heus J; Lu N; Nichols R C; Raben N; Plotz P H
Transcriptional regulation of the human acid alpha-glucosidase gene. Identification of a repressor element and its transcription factors Hes-1 and YY1.
The Journal of biological chemistry 2001;276(3):1789-93.
2000: Tezak Z; Nagaraju K; Plotz P; Hoffman E P
Adeno-associated virus in normal and myositis human skeletal muscle.
Neurology 2000;55(12):1913-7.
2000: Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim A E; Raben N; Plotz P; Rom W N
Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
Biochemical and biophysical research communications 2000;276(3):917-23.
2000: Nagaraju K; Raben N; Loeffler L; Parker T; Rochon P J; Lee E; Danning C; Wada R; Thompson C; Bahtiyar G; Craft J; Hooft Van Huijsduijnen R; Plotz P
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(16):9209-14.
2000: Raben N; Nagaraju K; Lee E; Plotz P
Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene.
Neuromuscular disorders : NMD 2000;10(4-5):283-91.
2000: Nagaraju K; Casciola-Rosen L; Rosen A; Thompson C; Loeffler L; Parker T; Danning C; Rochon P J; Gillespie J; Plotz P
The inhibition of apoptosis in myositis and in normal muscle cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(10):5459-65.
1999: Nagaraju K; Raben N; Villalba M L; Danning C; Loeffler L A; Lee E; Tresser N; Abati A; Fetsch P; Plotz P H
Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.
Clinical immunology (Orlando, Fla.) 1999;92(2):161-9.
1999: Amalfitano A; McVie-Wylie A J; Hu H; Dawson T L; Raben N; Plotz P; Chen Y T
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(16):8861-6.
1999: McCoy A L; Bubb M R; Plotz P H; Davis J C
Inclusion body myositis long after dermatomyositis: a report of two cases.
Clinical and experimental rheumatology 1999;17(2):235-9.
1999: Bartlett M L; Ginn L; Beitz L; Villalba M L; Plotz P; Bacharach S L
Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging.
Magnetic resonance imaging 1999;17(2):183-91.
1999: Adams E M; Pucino F; Yarboro C; Hicks J E; Thornton B; McGarvey C; Sonies B C; Bartlett M L; Villalba M L; Fleisher T; Plotz P H
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
The Journal of rheumatology 1999;26(2):352-60.
1999: Raben N; Lee E; Lee L; Hirschhorn R; Plotz P H
Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Online.
Human mutation 1999;13(1):83-4.
1998: Nagaraju K; Raben N; Merritt G; Loeffler L; Kirk K; Plotz P
A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli.
Clinical and experimental immunology 1998;113(3):407-14.
1998: Martiniuk F; Chen A; Mack A; Arvanitopoulos E; Chen Y; Rom W N; Codd W J; Hanna B; Alcabes P; Raben N; Plotz P
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease.
American journal of medical genetics 1998;79(1):69-72.
1998: Raben N; Nagaraju K; Lee E; Kessler P; Byrne B; Lee L; LaMarca M; King C; Ward J; Sauer B; Plotz P
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.
The Journal of biological chemistry 1998;273(30):19086-92.
1998: Becker J A; Vlach J; Raben N; Nagaraju K; Adams E M; Hermans M M; Reuser A J; Brooks S S; Tifft C J; Hirschhorn R; Huie M L; Nicolino M; Plotz P H
The African origin of the common mutation in African American patients with glycogen-storage disease type II.
American journal of human genetics 1998;62(4):991-4.
1998: Ginn L R; Lin J P; Plotz P H; Bale S J; Wilder R L; Mbauya A; Miller F W
Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases.
Arthritis and rheumatism 1998;41(3):400-5.
1998: Villalba L; Hicks J E; Adams E M; Sherman J B; Gourley M F; Leff R L; Thornton B C; Burgess S H; Plotz P H; Miller F W
Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens.
Arthritis and rheumatism 1998;41(3):392-9.
1997: Zaretsky J Z; Candotti F; Boerkoel C; Adams E M; Yewdell J W; Blaese R M; Plotz P H
Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion.
Human gene therapy 1997;8(13):1555-63.
1997: Adams E M; Kirkley J; Eidelman G; Dohlman J; Plotz P H
The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases.
Proceedings of the Association of American Physicians 1997;109(3):275-85.
1997: Adams E M; Becker J A; Griffith L; Segal A; Plotz P H; Raben N
Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans.
Human mutation 1997;10(2):128-34.
1997: Plotz P H
Deconstructing disease: an anatomy of illness in the age of molecular biology.
Perspectives in biology and medicine 1997;40(2):160-4.
1996: Hagiwara E; Adams E M; Plotz P H; Klinman D M
Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis.
Clinical and experimental rheumatology 1996;14(5):485-91.
1996: Nichols R C; Blinder J; Pai S I; Ge Q; Targoff I N; Plotz P H; Liu P
Assignment of two human autoantigen genes-isoleucyl-tRNA synthetase locates to 9q21 and lysyl-tRNA synthetase locates to 16q23-q24.
Genomics 1996;36(1):210-3.
1996: Raben N; Nichols R C; Martiniuk F; Plotz P H
A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II).
Human molecular genetics 1996;5(7):995-1000.
1996: Nichols R C; Rudolphi O; Ek B; Exelbert R; Plotz P H; Raben N
Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.
American journal of human genetics 1996;59(1):59-65.
1996: Kanik K S; Yarboro C H; Naparstek Y; Plotz P H; Wilder R L
Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis.
Arthritis and rheumatism 1996;39(6):1027-9.
1995: Finger D R; Plotz P H; Heywood G
Myositis following treatment with high dose interleukin-2 for malignancy.
The Journal of rheumatology 1995;22(11):2188.
1995: Nichols R C; Pai S I; Ge Q; Targoff I N; Plotz P H; Liu P
Localization of two human autoantigen genes by PCR screening and in situ hybridization--glycyl-tRNA synthetase locates to 7p15 and alanyl-tRNA synthetase locates to 16q22.
Genomics 1995;30(1):131-2.
1995: O'Hanlon T P; Dalakas M C; Plotz P H; Miller F W
The alpha beta T-cell receptor repertoire in idiopathic inflammatory myopathies: distinct patterns of gene expression by muscle-infiltrating lymphocytes in different clinical and serologic groups.
Annals of the New York Academy of Sciences 1995;756():410-3.
1995: O'Hanlon T P; Messersmith W A; Dalakas M C; Plotz P H; Miller F W
Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.
Clinical and experimental immunology 1995;100(3):519-28.
1995: Plotz P H; Rider L G; Targoff I N; Raben N; O'Hanlon T P; Miller F W
NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy.
Annals of internal medicine 1995;122(9):715-24.
1995: Adams E M; Chow C K; Premkumar A; Plotz P H
The idiopathic inflammatory myopathies: spectrum of MR imaging findings.
Radiographics : a review publication of the Radiological Society of North America, Inc 1995;15(3):563-74.
1995: Nichols R C; Raben N; Boerkoel C F; Plotz P H
Human isoleucyl-tRNA synthetase: sequence of the cDNA, alternative mRNA splicing, and the characteristics of an unusually long C-terminal extension.
Gene 1995;155(2):299-304.
1995: Boerkoel C F; Exelbert R; Nicastri C; Nichols R C; Miller F W; Plotz P H; Raben N
Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II.
American journal of human genetics 1995;56(4):887-97.
1995: Adams E M; Plotz P H
The treatment of myositis. How to approach resistant disease.
Rheumatic diseases clinics of North America 1995;21(1):179-202.
1995: Raben N; Exelbert R; Spiegel R; Sherman J B; Nakajima H; Plotz P; Heinisch J
Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.
American journal of human genetics 1995;56(1):131-41.
1995: Raben N; Nichols R C; Boerkoel C; Plotz P
Genetic defects in patients with glycogenosis type II (acid maltase deficiency).
Muscle & nerve 1995;3():S70-4.
1995: Raben N; Sherman J B; Adams E; Nakajima H; Argov Z; Plotz P
Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Muscle & nerve 1995;3():S35-8.
1994: Rider L G; Miller F W; Targoff I N; Sherry D D; Samayoa E; Lindahl M; Wener M H; Pachman L M; Plotz P H
A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children.
Arthritis and rheumatism 1994;37(10):1534-8.
1994: Raben N; Nichols R; Dohlman J; McPhie P; Sridhar V; Hyde C; Leff R; Plotz P
A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope.
The Journal of biological chemistry 1994;269(39):24277-83.
1994: Plotz P H
Reverse immunology: the lessons from myositis.
Clinical immunology and immunopathology 1994;72(2):204-7.
1994: Sherman J B; Raben N; Nicastri C; Argov Z; Nakajima H; Adams E M; Eng C M; Cowan T M; Plotz P H
Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.
American journal of human genetics 1994;55(2):305-13.
1994: O'Hanlon T P; Dalakas M C; Plotz P H; Miller F W
The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes.
Journal of autoimmunity 1994;7(3):321-33.
1994: O'Hanlon T P; Dalakas M C; Plotz P H; Miller F W
Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2569-76.
1993: Hicks J E; Miller F; Plotz P; Chen T H; Gerber L
Isometric exercise increases strength and does not produce sustained creatinine phosphokinase increases in a patient with polymyositis.
The Journal of rheumatology 1993;20(8):1399-401.
1993: Leff R L; Miller F W; Hicks J; Fraser D D; Plotz P H
The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy.
Medicine 1993;72(4):225-35.
1993: Joffe M M; Love L A; Leff R L; Fraser D D; Targoff I N; Hicks J E; Plotz P H; Miller F W
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
The American journal of medicine 1993;94(4):379-87.
1993: Raben N; Sherman J; Miller F; Mena H; Plotz P
A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease).
The Journal of biological chemistry 1993;268(7):4963-7.
1993: Naparstek Y; Plotz P H
The role of autoantibodies in autoimmune disease.
Annual review of immunology 1993;11():79-104.
1992: Plotz P H
Not myositis. A series of chance encounters.
JAMA : the journal of the American Medical Association 1992;268(15):2074-7.
1992: Targoff I N; Trieu E P; Plotz P H; Miller F W
Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.
Arthritis and rheumatism 1992;35(7):821-30.
1992: Plotz P H
The role of autoantigens in the induction and maintenance of autoimmunity.
Molecular biology reports 1992;16(3):127-32.
1992: Miller F W; Leitman S F; Cronin M E; Hicks J E; Leff R L; Wesley R; Fraser D D; Dalakas M; Plotz P H
Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.
The New England journal of medicine 1992;326(21):1380-4.
1992: Leff R L; Love L A; Miller F W; Greenberg S J; Klein E A; Dalakas M C; Plotz P H
Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle.
Lancet 1992;339(8803):1192-5.
1992: Raben N; Borriello F; Amin J; Horwitz R; Fraser D; Plotz P
Human histidyl-tRNA synthetase: recognition of amino acid signature regions in class 2a aminoacyl-tRNA synthetases.
Nucleic acids research 1992;20(5):1075-81.
1992: Plotz P H
New understanding of myositis.
Hospital practice (Office ed.) 1992;27(2A):33-43.
1991: Leff R L; Burgess S H; Miller F W; Love L A; Targoff I N; Dalakas M C; Joffe M M; Plotz P H
Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies.
Arthritis and rheumatism 1991;34(11):1391-6.
1991: Fraser D D; Frank J A; Dalakas M; Miller F W; Hicks J E; Plotz P
Magnetic resonance imaging in the idiopathic inflammatory myopathies.
The Journal of rheumatology 1991;18(11):1693-700.
1991: Love L A; Leff R L; Fraser D D; Targoff I N; Dalakas M; Plotz P H; Miller F W
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Medicine 1991;70(6):360-74.
1990: Miller F W; Waite K A; Biswas T; Plotz P H
The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(24):9933-7.
1990: Miller F W; Love L A; Barbieri S A; Balow J E; Plotz P H
Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.
Clinical and experimental immunology 1990;81(3):373-9.
1990: Cronin M E; Plotz P H
Idiopathic inflammatory myopathies.
Rheumatic diseases clinics of North America 1990;16(3):655-65.
1990: Miller F W; Twitty S A; Biswas T; Plotz P H
Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.
The Journal of clinical investigation 1990;85(2):468-75.
1989: Cronin M E; Miller F W; Hicks J E; Dalakas M; Plotz P H
The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy.
The Journal of rheumatology 1989;16(9):1225-8.
1989: Plotz P H; Dalakas M; Leff R L; Love L A; Miller F W; Cronin M E
Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders.
Annals of internal medicine 1989;111(2):143-57.
1988: Plotz P H; Miller F W
Animal models of myositis.
The Mount Sinai journal of medicine, New York 1988;55(6):501-5.
1988: Cronin M E; Love L A; Miller F W; McClintock P R; Plotz P H
The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization.
The Journal of experimental medicine 1988;168(5):1639-48.
1988: Maraia R; Zasloff M; Plotz P; Adeniyi-Jones S
Pathway of B1-Alu expression in microinjected oocytes: Xenopus laevis proteins associated with nuclear precursor and processed cytoplasmic RNAs.
Molecular and cellular biology 1988;8(10):4433-40.
1988: Biswas T; Miller F W; Plotz P H
Stimulation and partial stabilization of human histidyl-tRNA synthetase by hemoglobin.
FEBS letters 1988;229(1):203-5.
1988: Cronin M E; Plotz P H; Miller F W
Abnormalities of the immune system in the idiopathic inflammatory myopathies.
In vivo (Athens, Greece) 1988;2(1):25-9.
1987: Miller F W; Love L A; Biswas T; McClintock P R; Notkins A L; Plotz P H
Viral and host genetic factors influence encephalomyocarditis virus-induced polymyositis in adult mice.
Arthritis and rheumatism 1987;30(5):549-56.
1987: Biswas T; Miller F W; Takagaki Y; Plotz P H
An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum.
Journal of immunological methods 1987;98(2):243-8.
1987: Biswas T; Miller F W; Twitty S A; Plotz P H
An efficient method for enrichment of histidyl-tRNA synthetase (Jo-1 antigen) from HeLa cells.
Journal of immunological methods 1987;98(2):235-41.
1987: Klippel J H; Austin H A; Balow J E; leRiche N G; Steinberg A D; Plotz P H; Decker J L
Studies of immunosuppressive drugs in the treatment of lupus nephritis.
Rheumatic diseases clinics of North America 1987;13(1):47-56.
1987: Mullins W W; Plotz P H; Schrieber L
Soluble immune complexes in lupus mice: clearance from blood and estimation of formation rates.
Clinical immunology and immunopathology 1987;42(3):375-85.
1986: Austin H A; Klippel J H; Balow J E; le Riche N G; Steinberg A D; Plotz P H; Decker J L
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
The New England journal of medicine 1986;314(10):614-9.
1985: Schrieber L; Mullins W W; Plotz P H
Failure of methotrexate and methylprednisolone to alter the clearance of model immune complexes.
The Journal of rheumatology 1985;12(6):1044-7.
1985: Lehman T J; Allen J B; Plotz P H; Wilder R L
Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats.
Rheumatology international 1985;5(4):163-7.
1984: Plotz P H
Pulse therapy for SLE.
Clinical and experimental rheumatology 1984;2(4):283.
1984: Balow J E; Austin H A; Muenz L R; Joyce K M; Antonovych T T; Klippel J H; Steinberg A D; Plotz P H; Decker J L
Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
The New England journal of medicine 1984;311(8):491-5.
1984: Carette S; Macher A M; Nussbaum A; Plotz P H
Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health.
Seminars in arthritis and rheumatism 1984;14(1):52-9.
1984: Lehman T J; Allen J B; Plotz P H; Wilder R L
Lactobacillus casei cell wall-induced arthritis in rats: cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/N rats.
Arthritis and rheumatism 1984;27(8):939-42.
1984: Steinberg A D; Raveché E S; Laskin C A; Smith H R; Santoro T; Miller M L; Plotz P H
NIH conference. Systemic lupus erythematosus: insights from animal models.
Annals of internal medicine 1984;100(5):714-27.
1984: Fries L F; Mullins W W; Cho K R; Plotz P H; Frank M M
Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(2):695-700.
1983: Lehman T J; Allen J B; Plotz P H; Wilder R L
Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension.
Arthritis and rheumatism 1983;26(10):1259-65.
1983: Plotz P H
Autoantibodies are anti-idiotype antibodies to antiviral antibodies.
Lancet 1983;2(8354):824-6.
1983: Plotz P H
Analgesic nephropathy. For this time and for this place.
Archives of internal medicine 1983;143(9):1676-7.
1983: Lehman T J; Palmeri S T; Hastings C; Klippel J H; Plotz P H
Bacterial endocarditis complicating systemic lupus erythematosus.
The Journal of rheumatology 1983;10(4):655-8.
1983: Fields T R; Gerardi E N; Ghebrehiwet B; Bennett R S; Lawley T J; Hall R P; Plotz P H; Karsh J R; Frank M M; Hamburger M I
Reticuloendothelial system fc receptor function in rheumatoid arthritis.
The Journal of rheumatology 1983;10(4):550-7.
1983: Carette S; Klippel J H; Decker J L; Austin H A; Plotz P H; Steinberg A D; Balow J E
Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
Annals of internal medicine 1983;99(1):1-8.
1983: Williams H J; Ward J R; Reading J C; Egger M J; Grandone J T; Samuelson C O; Furst D E; Sullivan J M; Watson M A; Guttadauria M; Cathcart E S; Kaplan S B; Halla J T; Weinstein A; Plotz P H
Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
Arthritis and rheumatism 1983;26(5):581-92.
1982: Plotz P H
Studies on immune complexes.
Arthritis and rheumatism 1982;25(10):1151-5.
1982: Dinant H J; Decker J L; Klippel J H; Balow J E; Plotz P H; Steinberg A D
Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
Annals of internal medicine 1982;96(6 Pt 1):728-36.
1982: Hamburger M I; Lawley T J; Kimberly R P; Plotz P H; Frank M M
A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus.
Arthritis and rheumatism 1982;25(1):48-54.
1982: Plotz P H; Rifai A
Stable, soluble, model immune complexes made with a versatile multivalent affinity-labeling antigen.
Biochemistry 1982;21(2):301-8.
1981: Wei N; Pavlidis N; Tsokos G; Elin R J; Plotz P H
Clinical significance of low creatine phosphokinase values in patients with connective tissue diseases.
JAMA : the journal of the American Medical Association 1981;246(17):1921-3.
1981: Karsh J; Klippel J H; Plotz P H; Decker J L; Wright D G; Flye M W
Lymphapheresis in rheumatoid arthritis. A randomized trial.
Arthritis and rheumatism 1981;24(7):867-73.
1980: Karsh J; Kimberly R P; Stahl N I; Plotz P H; Decker J L
Comparative effects of aspirin and ibuprofen in the management of systemic lupus erythematosus.
Arthritis and rheumatism 1980;23(12):1401-4.
1979: Decker J L; Steinberg A D; Reinertsen J L; Plotz P H; Balow J E; Klippel J H
NIH conference. Systemic lupus erythematosus: evolving concepts.
Annals of internal medicine 1979;91(4):587-604.
1979: Plotz P H; Klippel J H; Decker J L; Grauman D; Wolff B; Brown B C; Rutt G
Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.
Annals of internal medicine 1979;91(2):221-3.
1979: Frank M M; Hamburger M I; Lawley T J; Kimberly R P; Plotz P H
Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.
The New England journal of medicine 1979;300(10):518-23.
1976: Plotz P; Kimberly R; Gill J R; Seaman W
Letter: Effect of salicylates on creatinine clearance.
British medical journal 1976;2(6032):421-2.
1976: Seaman W E; Plotz P H
Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers.
Arthritis and rheumatism 1976;19(2):155-60.
1975: Decker J L; Klippel J H; Plotz P H; Steinberg A D
Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
Annals of internal medicine 1975;83(5):606-15.
1975: Plotz P H
Autoimmunity in hepatitis.
The Medical clinics of North America 1975;59(4):869-76.
1975: Decker J L; Steinberg A D; Gershwin M E; Seaman W E; Klippel J H; Plotz P H; Paget S A
Systemic lupus erythematosus. Contrasts and comparisons.
Annals of internal medicine 1975;82(3):391-404.
1974: Seaman W E; Plotz P H; Ishak K G
Proceedings: Aspirin-induced hepatotoxicity in patients with RA or systemic lupus erythematosus (SLE).
Arthritis and rheumatism 1974;17(3):325.
1974: Scharschmidt B F; Plotz P H; Berk P D; Waggoner J G; Vergalla J
Removing substances from blood by affinity chromatography. II. Removing bilirubin from the blood of jaundiced rats by hemoperfusion over albumin-conjugated agarose beads.
The Journal of clinical investigation 1974;53(3):786-95.
1974: Plotz P H; Berk P D; Scharschmidt B F; Gordon J K; Vergalla J
Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads.
The Journal of clinical investigation 1974;53(3):778-85.
1974: Seaman W E; Ishak K G; Plotz P H
Letter: Aspirin and hepatotoxicity: addendum.
Annals of internal medicine 1974;80(2):279.
1974: Seaman W E; Ishak K G; Plotz P H
Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.
Annals of internal medicine 1974;80(1):1-8.
1973: Kimball H R; Wolff S M; Talal N; Plotz P H; Decker J L
Marrow granulocyte reserves in the rheumatic diseases.
Arthritis and rheumatism 1973;16(3):345-52.
1973: Salisbury K W; Plotz P H; Holland P V; Steinberg A D; Peppercorn M
Serologic abnormalities in systemic lupus erythematosus associated with viral hepatitis and tuberculosis.
Arthritis and rheumatism 1973;16(3):406-10.

Sign-in to see more